Clorox (CLX) Tops Q1 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Clorox (CLX) 1Q16 EPS Beat Driven by Top-Line Growth; UBS Raises Price Target to $105
November 3, 2015 8:43 AM ESTUBS reiterated a Sell rating on Clorox (NYSE: CLX), and raised the price target to $105.00 (from $103.00), following the company's 1Q16 earnings results. CLX posted a sizeable Q1 beat, delivering $1.32 in EPS (20% YOY growth) vs. consensus of $1.18. This outperformance was driven by greater FX-neutral top-line... More



